Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,047 | 75 | 100.0% |
| Education | $0.20 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $720.91 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $597.57 | 16 | $0 (2021) |
| Novo Nordisk Inc | $512.53 | 24 | $0 (2022) |
| kaleo, Inc. | $60.09 | 1 | $0 (2018) |
| Amgen Inc. | $50.96 | 3 | $0 (2018) |
| Alkermes, Inc. | $40.54 | 2 | $0 (2017) |
| Southern Implants North America Inc | $33.00 | 1 | $0 (2019) |
| Scilex Pharmaceuticals Inc. | $18.89 | 1 | $0 (2018) |
| Bausch Health US, LLC | $12.32 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.80 | 1 | Lilly USA, LLC ($27.80) |
| 2023 | $22.79 | 1 | Lilly USA, LLC ($22.79) |
| 2022 | $139.09 | 3 | Lilly USA, LLC ($99.47) |
| 2021 | $20.14 | 1 | AstraZeneca Pharmaceuticals LP ($20.14) |
| 2020 | $253.76 | 8 | AstraZeneca Pharmaceuticals LP ($176.22) |
| 2019 | $444.54 | 16 | Lilly USA, LLC ($212.63) |
| 2018 | $442.37 | 21 | Novo Nordisk Inc ($190.98) |
| 2017 | $696.32 | 25 | Novo Nordisk Inc ($251.03) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Diabetes | ||||||
| 07/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
| 10/05/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $99.47 | General |
| Category: Diabetes | ||||||
| 05/10/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 01/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Diabetes | ||||||
| 03/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes | ||||||
| 10/15/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 09/10/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Diabetes | ||||||
| 04/17/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 11/26/2019 | Southern Implants North America Inc | Provata (Device), Inverta | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Dental implant | ||||||
| 11/09/2019 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Education | In-kind items and services | $0.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $72.17 | General |
| Category: Diabetes | ||||||
| 09/19/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 09/19/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Diabetes | ||||||
| 06/26/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 04/04/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $77.07 | General |
| Category: Diabetes | ||||||
| 04/03/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 04/03/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 48 | 88 | $23,250 | $7,781 |
| 2022 | 2 | 50 | 79 | $21,500 | $7,732 |
| 2021 | 2 | 37 | 77 | $20,550 | $7,204 |
| 2020 | 2 | 33 | 76 | $20,700 | $5,840 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 53 | $16,100 | $5,284 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 35 | $7,150 | $2,497 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 52 | $15,700 | $5,728 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 27 | $5,800 | $2,004 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 51 | $15,300 | $5,517 | 36.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 26 | $5,250 | $1,687 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 41 | $13,850 | $3,953 | 28.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 35 | $6,850 | $1,887 | 27.5% |
About Dr. Albert Lee, MD
Dr. Albert Lee, MD is a Internal Medicine healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053389569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Lee, MD has received a total of $2,047 in payments from pharmaceutical and medical device companies, with $27.80 received in 2024. These payments were reported across 76 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($2,047).
As a Medicare-enrolled provider, Lee has provided services to 168 Medicare beneficiaries, totaling 320 services with total Medicare billing of $28,557. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bethesda, MD
- Active Since 03/09/2006
- Last Updated 10/03/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053389569
Products in Payments
- FARXIGA (Drug) $557.59
- TRULICITY (Drug) $491.86
- Victoza (Drug) $234.07
- Ozempic (Drug) $178.34
- MOUNJARO (Drug) $127.27
- EVZIO (Drug) $60.09
- Saxenda (Drug) $52.32
- Prolia (Biological) $50.96
- Vivitrol 380 mg (Drug) $40.54
- SYMBICORT (Drug) $39.78
- TRADJENTA (Drug) $39.61
- Provata (Device) $33.00
- Tresiba (Drug) $27.66
- JARDIANCE (Drug) $22.79
- HUMALOG (Drug) $20.66
- Rybelsus (Drug) $20.14
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $18.89
- BASAGLAR (Drug) $18.72
- WELLBUTRIN (Drug) $12.32
- CRESTOR (Drug) $0.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bethesda
Dr. Jay Shapiro, M.d, M.D
Internal Medicine — Payments: $96,294
Sandeep Rahangdale, M.d, M.D
Internal Medicine — Payments: $42,379
Dr. Christopher Lettieri, Md, MD
Internal Medicine — Payments: $40,731
Dr. Mihail Zilbermint, M.d, M.D
Internal Medicine — Payments: $20,885
Dr. Thanh Hoang, D.o, D.O
Internal Medicine — Payments: $17,556
Dr. Scott Williams, Md, MD
Internal Medicine — Payments: $17,162